DBV Technologies | GJELD



Debt Endring Dato
Acadia Pharmaceuticals USD 0 0 2024-12
Alnylam Pharmaceuticals USD 1.03B 945K 2025-03
Amarin USD 0 0 2024-09
BioMarin Pharmaceutical USD 595.65M 585K 2025-03
DBV Technologies USD 0 0 2024-09
Halozyme Therapeutics USD 1.51B 1.64M 2024-12
Incyte USD 37.12M 840K 2025-03
Insmed USD 1.13B 147.86M 2024-12
Ionis Pharmaceuticals USD 1.25B 5.23M 2025-03
Neurocrine Biosciences USD 0 0 2024-12
PTC Therapeutics USD 2.39B 389K 2024-12
Sarepta Therapeutics USD 1.14B 90.44M 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
United Therapeutics USD 200M 100M 2025-03



DBV Technologies GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.